Cargando…
Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo
BACKGROUND: Neuroglobin is considered to be a novel important pharmacological target in combating stroke and neurodegenerative disorders, although the mechanism by which this protection is accomplished remains an enigma. We hypothesized that if neuroglobin is directly involved in neuroprotection, th...
Autores principales: | Raida, Zindy, Hundahl, Christian Ansgar, Kelsen, Jesper, Nyengaard, Jens Randel, Hay-Schmidt, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487987/ https://www.ncbi.nlm.nih.gov/pubmed/22901501 http://dx.doi.org/10.1186/2040-7378-4-15 |
Ejemplares similares
-
Correction: Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo
por: Raida, Zindy, et al.
Publicado: (2013) -
Neuroglobin Over Expressing Mice: Expression Pattern and Effect on Brain Ischemic Infarct Size
por: Raida, Zindy, et al.
Publicado: (2013) -
Neuroglobin-Deficiency Exacerbates Hif1A and c-FOS Response, but Does Not Affect Neuronal Survival during Severe Hypoxia In Vivo
por: Hundahl, Christian Ansgar, et al.
Publicado: (2011) -
Circadian Behaviour in Neuroglobin Deficient Mice
por: Hundahl, Christian A., et al.
Publicado: (2012) -
Neuroglobin deficiency increases seizure susceptibility but does not affect basal behavior in mice
por: Gøtzsche, Casper R., et al.
Publicado: (2022)